ALLIE CAMPO: Open Payments
NPI 1265949358 · BROWNS MILLS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,668 in 109 payments from 21 companies in 2025. Trend: 2023 $1,438 · 2024 $1,981 · 2025 $1,668
Food & beverage: $1,668
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $290 |
| PFIZER INC. | 12 | $193 |
| ABBVIE INC. | 18 | $188 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $168 |
| Exact Sciences Corporation | 7 | $154 |
| GlaxoSmithKline, LLC. | 8 | $123 |
| Amgen Inc. | 6 | $91 |
| Corcept Therapeutics | 5 | $73 |
| Lilly USA, LLC | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
Products named: JARDIANCE, Rybelsus, Cologuard Collection Kit, Ozempic, ELIQUIS, OTEZLA, Korlym, UBRELVY.
Industry payments across NJ — which companies pay providers there.
